Jesus Figueroa
Overview
Explore the profile of Jesus Figueroa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alvarez X, Alvarez I, Martinez A, Romero I, Benito C, Suarez I, et al.
Int J Neuropsychopharmacol
. 2020 Jul;
23(9):581-586.
PMID: 32640027
Serum vascular endothelial growth factor (VEGF) increases with Alzheimer's disease (AD) severity and may prevent cognitive decline. However, information on the influence of AD drug therapy on circulating VEGF is...
2.
Alvarez X, Alvarez I, Iglesias O, Crespo I, Figueroa J, Aleixandre M, et al.
Int J Neuropsychopharmacol
. 2016 May;
19(6).
PMID: 27207906
Background: Low circulating brain derived neurotrophic factor may promote cognitive deterioration, but the effects of neurotrophic and combination drug therapies on serum brain derived neurotrophic factor were not previously investigated...
3.
Muresanu D, Ciurea A, Gorgan R, Gheorghita E, Florian S, Stan H, et al.
CNS Neurol Disord Drug Targets
. 2015 May;
14(5):587-99.
PMID: 25924999
Traumatic brain injury (TBI) is a leading cause of death and disability for which there is currently no effective drug therapy available. Because drugs targeting a single TBI pathological pathway...
4.
Alvarez X, Sampedro C, Figueroa J, Tellado I, Gonzalez A, Garcia-Fantini M, et al.
J Neural Transm (Vienna)
. 2008 Feb;
115(5):683-92.
PMID: 18273537
Changes in quantitative EEG (qEEG) recordings over a 1-year period and the effects of Cerebrolysin (Cere) on qEEG slowing and cognitive performance were investigated in postacute moderate-severe traumatic brain injury...
5.
Alvarez X, Sampedro C, Perez P, Laredo M, Couceiro V, Hernandez A, et al.
Int Clin Psychopharmacol
. 2003 Aug;
18(5):271-8.
PMID: 12920387
The potential effects of Cerebrolysin (EBEWE Pharma, Unterach, Austria), a peptide preparation with neurotrophic activity, on brain bioelectrical activity, cognitive performance and clinical outcome in postacute traumatic brain injury (TBI)...
6.
Farmer D, Anselmo D, Ghobrial R, Yersiz H, McDiarmid S, Cao C, et al.
Ann Surg
. 2003 May;
237(5):666-75; discussion 675-6.
PMID: 12724633
Objective: To analyze outcomes after liver transplantation (LT) in patients with fulminant hepatic failure (FHF) with emphasis on pretransplant variables that can potentially help predict posttransplant outcome. Summary Background Data:...